What's new

Presentation - The summary-of-product-characteristics guideline and paediatric aspects

Presentation - The summary-of-product-characteristics guideline and paediatric aspects

Jun 12, 2025 - 15:05
 0
Presentation - The summary-of-product-characteristics guideline and paediatric aspects
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Doptelet, avatrombopa...

Next Article

NATO Deputy Secretary General addresses the Brussels Forum on Transatlantic Defence

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0099/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 5, 2025  0

Plasma master file certificates

Plasma master file certificates

Jun 2, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0117/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 11, 2025  0